Ye T, Li C, Zhang X Q, Shao Y M, Huang Q, Cui S J, Zhou B
Department of Otorhinolaryngology Head and Neck Surgery, Beijing TianTan Hospital, Capital Medical University, Beijing 100050, China.
Department of Otorhinolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing 100730, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Aug 7;57(8):915-922. doi: 10.3760/cma.j.cn115330-20211215-00797.
To summarize the follow-up outcomes of frontal drill out procedures (draf Ⅱb, extended draf Ⅱb and draf Ⅲ) using mucosal flaps, and discuss the surgical indications of different mucosal flaps and their potential benefits to the opening of the frontal neo-ostium. A total of 48 patients with chronic rhinosinusitis or frontal mucoceles treated by draf Ⅱb, extended draf Ⅱb and draf Ⅲ between 2013 and 2019 in Beijing TongRen Hospital were enrolled in this study. Twenty-four patients who were treated with mucosal flaps were considered as mucosal flap group (including 19 males and 5 females, aging from 19 to 71 years), and the other 24 patients who didn't have neo-ostium reconstruction were considered as control group (including 18 males and 6 females, aging from 21 to 63 years). The frontal neo-ostium crosssectional area was measured with osiriX 7 days and 1 year postoperatively. Lund-Kennedy score (LKS) was also completed to analyze the difference of therapeutic effect between mucosal flap group and control group. SPSS 23.0 software was used for statistical analysis. The postoperative follow-up time was 18 to 102 months. The postoperative epithelialization time in the mucosal flap group and the control group was (2.5±0.9) months and (3.0±0.7) months (Mean±SD), respectively, with statistically significant (=1.97, =0.024). At the end of follow-up, 23 cases (95.8%) had well opened frontal neo-ostium, 1 case (4.2%) was re-stenosed, and there was no revision surgery in the mucosal flap group. In the control group, 16 cases (66.7%) had well opened frontal neo-ostium, 8 cases (33.3%) were re-stenosed, 4 cases (16.7%) had revision surgery. The mucosal flap group had much fewer stenosis cases than control group (=4.92, =0.027). The neo-ostium area in the mucosal flap group and the control group was reduced by (0.87±0.58) cm and (1.54±1.15) cm 1 year after operation respectively, with statistically significant (=1.72, =0.046). There was no case of frontal sinus atresia and no surgical complication in both groups. The two-factor repeated measurement analysis of variance after surgery showed that the average LKS of the mucosal flap group was 0.78 points lower than that of the control group. In other words, the influence of grafting technique on LKS was statistically significant (=5.33, =0.035). The application of mucosal flaps to cover the denuded bone during frontal drill out procedures can prohibit mucosal scar and new bone formation, and significantly reduce the stenosis rate of frontal neo-ostium.
总结采用黏膜瓣的额窦钻孔手术(DrafⅡb、改良DrafⅡb和DrafⅢ)的随访结果,探讨不同黏膜瓣的手术适应证及其对额窦新开口的潜在益处。本研究纳入了2013年至2019年在北京同仁医院接受DrafⅡb、改良DrafⅡb和DrafⅢ治疗的48例慢性鼻窦炎或额窦黏液囊肿患者。24例采用黏膜瓣治疗的患者被视为黏膜瓣组(包括19例男性和5例女性,年龄19至71岁),另外24例未进行新开口重建的患者被视为对照组(包括18例男性和6例女性,年龄21至63岁)。术后7天和1年使用OsiriX测量额窦新开口的横截面积。还完成了Lund-Kennedy评分(LKS)以分析黏膜瓣组和对照组之间治疗效果的差异。使用SPSS 23.0软件进行统计分析。术后随访时间为18至102个月。黏膜瓣组和对照组术后上皮化时间分别为(2.5±0.9)个月和(3.0±0.7)个月(均值±标准差),差异有统计学意义(t=1.97,P=0.024)。随访结束时,黏膜瓣组23例(95.8%)额窦新开口良好,1例(4.2%)再次狭窄,且无翻修手术。对照组中,16例(66.7%)额窦新开口良好,8例(33.3%)再次狭窄,4例(16.7%)接受了翻修手术。黏膜瓣组狭窄病例明显少于对照组(χ²=4.92,P=0.027)。术后1年黏膜瓣组和对照组新开口面积分别减少(0.87±0.58)cm²和(1.54±1.15)cm²,差异有统计学意义(t=1.72,P=0.046)。两组均无额窦闭锁病例,也无手术并发症。术后双因素重复测量方差分析显示,黏膜瓣组的平均LKS比对照组低0.78分。换句话说,移植技术对LKS的影响有统计学意义(F=5.33,P=0.035)。在额窦钻孔手术中应用黏膜瓣覆盖裸露的骨面可防止黏膜瘢痕和新骨形成,并显著降低额窦新开口的狭窄率。